引用本文:朱凌霄,肖 春,张建华.液体活检在转移性乳腺癌诊疗中的应用进展[J].中国临床新医学,2022,15(11):1017-1022.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1028次   下载 773 本文二维码信息
码上扫一扫!
分享到: 微信 更多
液体活检在转移性乳腺癌诊疗中的应用进展
朱凌霄,肖 春,张建华
100088 北京,中国人民解放军火箭军特色医学中心普通外科
摘要:
[摘要] 乳腺癌是高度异质性的疾病,而转移性乳腺癌作为其中预后最差的类型,目前标准治疗方式仍是全身治疗。临床上会根据患者的疾病进展情况,制定个体化治疗方案来改善患者的生存质量。液体活检是对体液进行采样和分析的过程,可以对多项肿瘤指标进行连续性监测。该文就液体活检技术在转移性乳腺癌诊疗中的应用进展作一综述。
关键词:  液体活检  转移性乳腺癌  研究进展
DOI:10.3969/j.issn.1674-3806.2022.11.04
分类号:R 737.9
基金项目:
Recent advances in application of liquid biopsy in diagnosis and treatment of metastatic breast cancer
ZHU Ling-xiao, XIAO Chun, ZHANG Jian-hua
Department of General Surgery, PLA Rocket Force Characteristic Medical Center, Beijing 100088, China
Abstract:
[Abstract] Breast cancer is a highly heterogeneous disease, and metastatic breast cancer is the type with the worst prognosis. At present, the standard treatment of metastatic breast cancer is still systemic treatment. Clinically, accordingto the disease progression of patients, individualized treatment plans are formulated to improve the quality of life of the patients. Liquid biopsy is a process in which body fluids are sampled and analyzed, allowing continuous monitoring of multiple tumor indicators. This paper reviews the recent advances in application of liquid biopsy in diagnosis and treatment of metastatic breast cancer.
Key words:  Liquid biopsy  Metastatic breast cancer  Recent advances